Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 45963-142
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 45963-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
300mg (Image 2)
This is a medication guide for a drug called "P-i-el" once daily 300 in extended-release tablets form. The medication contains hydrochloride and must be stored in a tight, light-resistant container. The dosage should be taken daily, and users should not exceed the recommended dosage. The text also provides a warning not to use this medication in combination with another drug called "ZYBAN®" or any other medicines that contain bupropion hydrochloride.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.